Immunization News and Research

RSS

Columbia University, FairChoice Systems sign agreement to market student health information system

Columbia University and FairChoice Systems, Inc. have signed a multi-year commercialization agreement that will bring to market a cost-effective, online student health information system developed and implemented by Columbia University's own Student Health Services.

2 Mar 2010

HMS initiates new interoperability product for customers

Healthcare Management Systems, Inc. ® announced today the launch of a new interoperability product for customers that will enable the exchange of clinical data between third party systems, health information exchanges, and public registries. The new product will assist clients in qualifying for the American Recovery and Reinvestment Act HITECH stimulus funds.

2 Mar 2010

Researchers proceed to develop vaccination to reverse neurological damage seen with Parkinson's disease

Researchers at the University of Nebraska Medical Center have taken a significant step forward in developing a vaccination approach to reverse the neurological damage seen with Parkinson's disease.

2 Mar 2010

Axolotl to demonstrate Elysium Open Access platform during HIMSS 2010

Axolotl Corp., the most experienced health information exchange (HIE) solutions and services company, today announced that it will be demonstrating its standards-based service-oriented architecture (SOA) platform — Elysium Open Access, with live third party applications – in operation today. Elysium Open Access is a core part of Axolotl’s Elysium® Exchange HIE suite.

1 Mar 2010

Widespread cases of flu plunge from 49 to zero

Normally, this is the peak period for the flu in the United States. But that just doesn't seem to be the case this year.

27 Feb 2010

Possible damage to children caused by compulsory vaccines: CVS calls for investigation of federal agencies

In a letter to the Chairmen and Ranking Members of House and Senate Committees charged with oversight of the Department of Health and Human Services (HHS), the Coalition for Vaccine Safety (CVS) is calling for hearings to investigate HHS, the Centers for Disease Control (CDC) and other government agencies for failure to fully address issues of vaccine safety as intended by the Mandate for Safer Vaccines in the 1986 National Childhood Vaccine Injury Compensation Act.

26 Feb 2010

CDC ACIP's vote for universal influenza vaccination recommendation: FFF endorses

Families Fighting Flu (FFF) fully supports today's vote by the Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) to expand the current influenza vaccination recommendations to include all adults aged 19 to 49 years of age. Previous recommendations included all other age groups with the exception of this new adult population. This new recommendation will be implemented beginning with the 2010-2011 influenza season.

25 Feb 2010

American Lung Association supports ACIP's recommendations for universal influenza immunization

The American Lung Association supports the Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices' (ACIP) vote today that recommends universal influenza immunization with seasonal influenza vaccine.

25 Feb 2010

FDA approves Pfizer's Prevnar 13 pneumococcal conjugate vaccine

Pfizer Inc. announced today that the United States Food and Drug Administration has granted approval for Prevnar 13™ (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]), the Company’s 13-valent pneumococcal conjugate vaccine.

25 Feb 2010

Also in global health news: Infant, maternal mortality in N. Korea; malaria in Cambodia; Zambia PEPFAR program; Pakistan's anti-polio campaign; U.N. Ambassador responds to Somalia; Myanmar refugees

Higher rates of infant and maternal mortality have lead to a decline of life expectancy in North Korea over the past 15 years, census figures, which were obtained with help form the U.N. Population Fund, said on Monday, Agence France-Presse reports (2/22).

23 Feb 2010

P4P programs may be effective in incentivizing low performing physicians: Study

Pay-for-performance (P4P) programs are payment models that reward workers for meeting certain performance measures for quality and efficiency. In the healthcare setting, P4P programs use a variety of methods to reward physicians financially for achieving targets, including fee differentials and bonuses.

20 Feb 2010

VIRxSYS announces results from prophylactic HIV vaccine study at 2010 CROI conference

VIRxSYS Corporation, a privately held company developing vaccines and RNA therapies for serious human diseases such as HIV and cardiovascular diseases, announced results from its prophylactic HIV vaccine (VRX1023) study in Rhesus Macaque monkeys during a presentation today at the 2010 Annual Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco, CA.

19 Feb 2010

Upp Technology adds Vaccine Provider Registration System to irms software suite

Upp Technology, a leader in public health software solutions, announced today at the Public Health Preparedness Summit, that it has enhanced its suite of irms software with the addition of the irms Vaccine Provider Registration System. The new provider management solution is already running in multiple states and the company expects to announce the deployment of this system in another four states within the first quarter of 2010.

18 Feb 2010

Phase III data reveals potential of Merck’s GARDASIL in preventing HPV and HPV-related cancers

Merck & Co., Inc. announced today that in new Phase III data, GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant] was 77.5 percent (95 percent CI: 39.6, 93.3) efficacious against anal intraepithelial neoplasia (AIN) associated with human papillomavirus (HPV) types 6, 11, 16 and 18 in 16-to-26 year-old men who have sex with men. The data were presented at the European Research Organization on Genital Infection and Neoplasia (EUROGIN) conference in Monte Carlo, Monaco.

18 Feb 2010

New method may help assess impact and cost-effectiveness of flu vaccination campaigns

A new study (doi:10.1016/j.vaccine.2010.01.002), published by Elsevier this month in Vaccine (http://www.elsevier.com/locate/vaccine) describes a new method that assesses the impact and cost-effectiveness of a range of vaccination options.

10 Feb 2010

Whooping cough vaccine may be losing its punch: study

Vaccination programs against whooping cough may not be fully effective because the bacteria that cause the disease have evolved new strains, a new study has found.

9 Feb 2010

Novavax announces new data from trivalent seasonal influenza VLP vaccine study

Novavax, Inc. announced today new data from a clinical study that began in May of 2009 among healthy adults 18 to 49 years of age with Novavax's trivalent seasonal influenza Virus-like Particle (VLP) vaccine. The vaccine matched the influenza strains recommended for the 2008-2009 influenza season including H1N1 A/Brisbane/59/2007, H3N2 A/Brisbane/10/2007, and B/Florida/04/2006 strains.

9 Feb 2010

Inovio Biomedical announces additional immunogenicity data from therapeutic cervical cancer vaccine trial

Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today additional interim safety and immunogenicity data from its therapeutic cervical cancer vaccine (VGX-3100) trial. VGX-3100 is a DNA vaccine targeting the E6 and E7 proteins of human papillomavirus (HPV) types 16 and 18 and is delivered via in vivo electroporation.

8 Feb 2010

New report finds low adult vaccination rates in U.S.

A new report, Adult Immunization: Shots to Save Lives, released today by the Trust for America's Health (TFAH), the Infectious Diseases Society of America (IDSA), and the Robert Wood Johnson Foundation (RWJF) found that more than 30 percent of adults ages 65 and older had not been immunized against pneumonia in 36 states as of 2008.

5 Feb 2010

U.N. taps Bill Clinton to lead Haiti rebuilding; 200,000 people died in quake, Haitian PM says

U.N. Secretary-General Ban Ki-moon on Wednesday asked former President Bill Clinton, currently the U.N. special envoy for Haiti, to oversee aid and rebuilding efforts in Haiti, CNN reports (2/3).

5 Feb 2010

Immunization News and Research

Columbia University, FairChoice Systems sign agreement to market student health information system

HMS initiates new interoperability product for customers

Researchers proceed to develop vaccination to reverse neurological damage seen with Parkinson's disease

Axolotl to demonstrate Elysium Open Access platform during HIMSS 2010

Widespread cases of flu plunge from 49 to zero

Possible damage to children caused by compulsory vaccines: CVS calls for investigation of federal agencies

CDC ACIP's vote for universal influenza vaccination recommendation: FFF endorses

American Lung Association supports ACIP's recommendations for universal influenza immunization

FDA approves Pfizer's Prevnar 13 pneumococcal conjugate vaccine

Also in global health news: Infant, maternal mortality in N. Korea; malaria in Cambodia; Zambia PEPFAR program; Pakistan's anti-polio campaign; U.N. Ambassador responds to Somalia; Myanmar refugees

P4P programs may be effective in incentivizing low performing physicians: Study

VIRxSYS announces results from prophylactic HIV vaccine study at 2010 CROI conference

Upp Technology adds Vaccine Provider Registration System to irms software suite

Phase III data reveals potential of Merck’s GARDASIL in preventing HPV and HPV-related cancers

New method may help assess impact and cost-effectiveness of flu vaccination campaigns

Whooping cough vaccine may be losing its punch: study

Novavax announces new data from trivalent seasonal influenza VLP vaccine study

Inovio Biomedical announces additional immunogenicity data from therapeutic cervical cancer vaccine trial

New report finds low adult vaccination rates in U.S.

U.N. taps Bill Clinton to lead Haiti rebuilding; 200,000 people died in quake, Haitian PM says

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News